Aug 2026· Drug and Alcohol Dependence· Vol 287, pp.
113331
· 0 citations· 35 references
Medicine
TL;DR
It is indicated that ethanol potentiated the reinforcing effects of cocaine + nicotine, and future studies should incorporate polysubstance use into preclinical models to model the human condition and to evaluate interventions for CUD.
Abstract
Background
Polysubstance use is common in cocaine use disorder (CUD), yet most preclinical models still study cocaine in isolation. A recent Pharmacological Reviews article (Rough and Nader, 2026) from our group identified a major preclinical gap: despite epidemiologic evidence that most people who use cocaine also co-use alcohol and nicotine, no preclinical studies have modeled this three-drug combination. In prior studies from our laboratory, adding nicotine to cocaine under a choice procedure increased cocaine's reinforcing potency and strength, whereas oral ethanol self-administration prior to cocaine self-administration under a choice procedure increased cocaine's reinforcing strength without altering potency.
Methods
Building on these findings, we developed a three-drug model in which oral ethanol or vehicle was available simultaneously while monkeys (N = 6; 4 females, 2 males) chose between food pellets and intravenous cocaine or cocaine + nicotine.
Results
Nicotine increased cocaine choice under both ethanol and vehicle conditions. While ethanol did not alter the reinforcing potency of cocaine alone, it increased the potency of cocaine + nicotine relative to vehicle.
Conclusion
Together, these findings indicate that ethanol potentiated the reinforcing effects of cocaine + nicotine. Future studies should incorporate polysubstance use into preclinical models to model the human condition and to evaluate interventions for CUD.
Cocaine use disorder (CUD) can be modeled preclinically using different temporal cocaine self-administration access conditions. For example, intermittent-access (IntA) procedures typically use cycles of brief (e.g., 5 min) cocaine-access periods separated by longer (e.g., 25 min) time-outs to generate bouts of high-rat...
Samuel A. Marsh, S. S. Negus, Matthew L. Banks· Neuropsychopharmacology· 0 citations
BACKGROUND
The co-use of opioids, primarily fentanyl, and stimulants has resulted in substantial increases in fatal multi-drug overdoses, yet few studies have systematically investigated the reinforcing effects of fentanyl + stimulant mixtures. Behavioral economic demand curve analyses can quantify the relative value o...
Jacqueline M. Vazquez, Harmony I. Risca, G. Collins· Drug and Alcohol Dependence· 0 citations
OBJECTIVE
Most alcohol is consumed in solution with sweeteners or other carbohydrates. Nicotine produces value-enhancing effects on other reinforcers, including sucrose and alcohol. The present study examined nicotine's value-enhancing effects on sucrose, alcohol, and sweetened alcohol self-administration in male and f...
Scott T. Barrett, Anthony T. Raimondi, Andrew P. Finkner et al.· Preventive Medicine· 0 citations
Background Alcohol and cannabinoids are frequently used during pregnancy, however their combined effects on offspring outcomes are currently under-investigated. In this study, co-exposure was compared to single-drug and drug-free exposures for influences on adult alcohol-seeking and cannabinoid system proteomics. Metho...
Siara K. Rouzer, Abigail V. Bowring, Aisley George et al.· bioRxiv· 0 citations
Although methamphetamine addiction and fatality rates are on the rise in the United States, there are currently no FDA approved drugs to treat methamphetamine use disorder (MUD). To better understand factors contributing to addiction, researchers have used various rodent models of stress including footshock, social def...
Kayla B. Cox, Nicole C. Reyna, Carlos Maestas-Olguin et al.· Pharmacology, Biochemistry a...· 0 citations
Background The nicotine analog 6-methyl nicotine (6-MN) has appeared in commercial e-cigarette liquids, and other products, spurring interest in determining the extent to which it conveys similar effects to those of nicotine. Objective To determine if 6-MN acts like nicotine to decrease body temperature, decrease nocic...
M. Taffe, Helen S. Kim, Tess A. Doran et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.